Yongfeng Shang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Multiple Myeloma

Histone Deacetylase

Papillary Thyroid

Genome Wide Association Study

Top Venues

Nature communications

The EMBO journal

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Yazi Yang, Sen Qin, Mengyu Yang, Ting Wang, Ru Feng, Chunli Zhang, Enrun Zheng, Qinghua Li, Pengyu Xiang, Shangyong Ning, Xiaodong Xu, Xin Zuo, Shuai Zhang, Xiaoya Yun, Xuehong Zhou, Yue Wang, Lin He, Yongfeng Shang, Luyang Sun, Hongmei Jing
Reconstitution of the Multiple Myeloma Microenvironment Following Lymphodepletion with BCMA CAR-T Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Yani Peng, Xiaoping Liu, Xinhua Liu, Xiao Cheng, Lu Xia, Leyi Qin, Sudun Guan, Yue Wang, Xiaodi Wu, Jiajing Wu, Dong Yan, Jianying Liu, Yu Zhang, Luyang Sun, Jing Liang, Yongfeng Shang
RCCD1 promotes breast carcinogenesis through regulating hypoxia-associated mitochondrial homeostasis. Oncogene (2023)
Wenting Zhang, Yue Wang, Yongjie Liu, Cuifang Liu, Yizhou Wang, Lin He, Xiao Cheng, Yani Peng, Lu Xia, Xiaodi Wu, Jiajing Wu, Yu Zhang, Luyang Sun, Ping Chen, Guohong Li, Qiang Tu, Jing Liang, Yongfeng Shang
NFIB facilitates replication licensing by acting as a genome organizer. Nature communications 14 (1) (2023)
Xing Chen, Chunyu Yu, Xinhua Liu, Beibei Liu, Xiaodi Wu, Jiajing Wu, Dong Yan, Lulu Han, Zifan Tang, Xinyi Yuan, Jian-Qiu Wang, Yue Wang, Shumeng Liu, Lin Shan, Yongfeng Shang
Intracellular galectin-3 is a lipopolysaccharide sensor that promotes glycolysis through mTORC1 activation. Nature communications 13 (1) (2022)
Zihan Zhang, Xiaoping Liu, Lei Li, Yang Yang, Jianguo Yang, Yue Wang, Jiajing Wu, Xiaodi Wu, Lin Shan, Fei Pei, Jianying Liu, Shu Wang, Wei Li, Luyang Sun, Jing Liang, Yongfeng Shang
SNP rs4971059 predisposes to breast carcinogenesis and chemoresistance via TRIM46-mediated HDAC1 degradation. The EMBO journal 40 (19) (2021)